Eversept Partners LP Takes Position in Chemed Corporation $CHE

Eversept Partners LP purchased a new stake in shares of Chemed Corporation (NYSE:CHE) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 31,057 shares of the company’s stock, valued at approximately $11,731,000.

Other institutional investors have also added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. lifted its position in Chemed by 2,444,879.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after buying an additional 5,549,876 shares during the period. JPMorgan Chase & Co. grew its position in shares of Chemed by 4.4% in the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock worth $223,301,000 after buying an additional 21,932 shares during the period. AQR Capital Management LLC increased its stake in shares of Chemed by 89.2% in the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock worth $139,302,000 after acquiring an additional 153,469 shares in the last quarter. TD Asset Management Inc increased its stake in shares of Chemed by 7.5% in the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after acquiring an additional 22,715 shares in the last quarter. Finally, Epoch Investment Partners Inc. increased its stake in shares of Chemed by 4.9% in the 4th quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock worth $137,945,000 after acquiring an additional 15,133 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

Shares of NYSE CHE opened at $508.30 on Tuesday. The firm’s 50-day moving average price is $459.92 and its 200-day moving average price is $434.09. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. The company has a market cap of $6.75 billion, a PE ratio of 27.70, a PEG ratio of 1.88 and a beta of 0.52. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $517.74.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were issued a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s dividend payout ratio (DPR) is currently 13.08%.

Insider Activity at Chemed

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the sale, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 3.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on CHE shares. Royal Bank Of Canada boosted their price objective on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Bank of America lifted their target price on shares of Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Chemed presently has an average rating of “Hold” and a consensus target price of $480.25.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.